Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral and Gastric H. pylori Infection Factors and Eradication Analysis
NCT05455372Unknown
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jul 2022
- Primary completion
- Sep 2023
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Open-label trial of ilaprazole, amoxicillin, clarithromycin and colloidal bismuth tartrate in Helicobacter pylori infection (4 arms), sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: Oral and gastric H. pylori infection rate at 1 year, The affecting factors of oral and gastric H. pylori infection at 1 year and 2 more. Status: unknown.
02
Drugs
ilaprazoleamoxicillinclarithromycincolloidal bismuth tartrate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05455372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05455372.